Cisplatin Plus Vinorelbine With or Without Tirapazamine in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer
Part of paid clinical trials in Los Angeles, California.
- Sponsor
- Sanofi
- Study ID
- NCT00017459
- Phase
- PHASE3
- Status
- Completed
Conditions
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- cisplatin — DRUG
- tirapazamine — DRUG
- vinorelbine tartrate — DRUG
Study Details
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. It is not yet known if cisplatin and vinorelbine are more effective with or without tirapazamine in treating non-small cell lung cancer PURPOSE: Randomized phase III trial to compare the effectiveness of cisplatin plus vinorelbine with or without tirapazamine in treating patients who have stage IIIB or stage IV non-small cell lung cancer.
Key Dates
- Start date
- Jul 31, 2000
- Status verified
- Feb 2010
- Completion
- Feb 29, 2004
Study Design
- Primary purpose
- TREATMENT
Locations (42)
Find similar trials in Los Angeles, CA
By condition
By specialty
By research site
Medical Oncology Internal Medicine· Los Angeles, CATower Hematology Oncology Medical Group· Los Angeles, CABay Area Tumor Institute· Oakland, CAMedical Oncology Care Associates· Orange, CAUCSF Cancer Center and Cancer Research Institute· San Francisco, CAJohn Wayne Cancer Institute· Santa Monica, CA
Related Studies
- Detection of Genetic Markers of Lung CancerRecruiting · University of Pittsburgh · Pittsburgh, Pennsylvania
- Lung Cancer Biomarkers and ScreeningRecruiting · NYU Langone Health · New York, New York
- Identification of Secreted Markers for Tumor Hypoxia in Patients With Head and Neck or Lung CancersRecruiting · Stanford University · Stanford, California
- Studying Tumor Tissue Samples and Blood Samples to Learn More About DNA Changes in Patients With Lung CancerRecruiting · University of California, Davis · Sacramento, California